Molecular model of the malaria drug chloroquine bound to the enzyme lactate dehydrogenase. This enzyme is involved in glycolysis, the metabolic pathway that produces energy from glucose. Chloroquine acts as a competitive inhibitor of the enzyme in the malaria parasite Plasmodium falciparum, disrupting glycolysis.
Model release not required. Property release not required.